APOC3 and coronary artery disorder: Even the antiatherogenic function of HDL was also impaired by apoCIII in CHD patients [15], and elevated apoCIII content in HDL (HDL-apoCIII) predicted the occurrence and progression of CHD in prospective or retrospective studies [16–18].